Recently, a collaborative study between the groups of ConLiGen and Pharmacogenomics of Bipolar Disorder demonstrated an association between lithium prophylaxis with focal adhesion and the PI3K-Akt signaling pathway, which are connected, i.a., with the proliferation and growth of the cell [158]. Here, AKT1 is linked to bipolar disorder.